-
公开(公告)号：US20190071452A1
公开(公告)日：2019-03-07
申请号：US16122116
申请日：2018-09-05
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara
IPC: C07D495/22 , A61P25/28 , A61P25/16
Abstract: The present invention provides compounds represented by formulas (I) to (VI) or pharmaceutically acceptable salts thereof.
-
公开(公告)号：US11420980B2
公开(公告)日：2022-08-23
申请号：US17021544
申请日：2020-09-15
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Kenshi Yoshida , Yoshiaki Ohashi , Tamaki Hoshikawa , Nobuaki Sato , Ikuo Kushida
IPC: C07D495/22 , A61P25/28 , A61P25/00 , A61P25/16
Abstract: Salts of the compound represented by formula (I) or crystals thereof have a potential use as drug substances for pharmaceuticals.
-
公开(公告)号：US11267821B2
公开(公告)日：2022-03-08
申请号：US16807335
申请日：2020-03-03
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara , Nobuaki Sato , Shinsuke Hirota , Takaaki Harada , Hikaru Yoshimura
IPC: C07D495/22 , A61K31/551 , A61P25/00 , C07D491/22 , C07D491/147
Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US20170137436A1
公开(公告)日：2017-05-18
申请号：US15346912
申请日：2016-11-09
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Toshiki Kurokawa , Yu Yoshida , Kogyoku Shin , Yoshihisa Kobayashi , Hironori Fukumoto , Kunitoshi Takeda , Yoshiaki Ohashi , Makoto Kotake , Tomoyuki Shibuguchi , Toru Watanabe , Yoichi Kita , Shinsuke Hirota , Takashi Fukuyama , Yasuaki Kamada
IPC: C07D491/147 , C07D491/052
CPC classification number: C07D491/147 , C07D491/052
Abstract: Compounds represented by formulae (I) to (XXII) or pharmaceutically acceptable salts thereof:
-
Patent Agency Ranking
公开(公告)号：US10239889B1
公开(公告)日：2019-03-26
申请号：US16122116
申请日：2018-09-05
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara
IPC: A61K31/551 , A61P25/00 , C07D495/22 , A61P25/16 , A61P25/28
Abstract: The present invention provides compounds represented by formulas (1) to (VI) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US09738656B2
公开(公告)日：2017-08-22
申请号：US15346912
申请日：2016-11-09
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Toshiki Kurokawa , Yu Yoshida , Kogyoku Shin , Yoshihisa Kobayashi , Hironori Fukumoto , Kunitoshi Takeda , Yoshiaki Ohashi , Makoto Kotake , Tomoyuki Shibuguchi , Toru Watanabe , Yoichi Kita , Shinsuke Hirota , Takashi Fukuyama , Yasuaki Kamada
IPC: C07D491/147 , C07D491/052
CPC classification number: C07D491/147 , C07D491/052
Abstract: Compounds represented by formulae (I) to (XXII) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US11358972B2
公开(公告)日：2022-06-14
申请号：US16807335
申请日：2020-03-03
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara , Nobuaki Sato , Shinsuke Hirota , Takaaki Harada , Hikaru Yoshimura
IPC: C07D495/22 , A61K31/551 , A61P25/00 , C07D491/22 , C07D491/147
Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US20210024541A1
公开(公告)日：2021-01-28
申请号：US17021544
申请日：2020-09-15
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Kenshi Yoshida , Yoshiaki Ohashi , Tamaki Hoshikawa , Nobuaki Sato , Ikuo Kushida
IPC: C07D495/22 , A61P25/00 , A61P25/28 , A61P25/16
Abstract: Salts of the compound represented by formula (I) or crystals thereof have a potential use as drug substances for pharmaceuticals.
-
公开(公告)号：US20200283452A1
公开(公告)日：2020-09-10
申请号：US16807335
申请日：2020-03-03
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara , Nobuaki Sato , Shinsuke Hirota , Takaaki Harada , Hikaru Yoshimura
IPC: C07D495/22 , C07D491/147 , C07D491/22
Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.027 seconds)
